Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature
Tumor-induced osteomalacia (TIO), or oncogenic osteomalacia (OOM), is a rare acquired Paraneoplastic disease characterized by renal phosphate wasting and hypophosphatemia. Recent evidence shows that tumor-overexpressed fibroblast growth factor 23 (FGF23) is responsible for the hypophosphatemia and o...
Main Authors: | Hu, Fang-Ke, Yuan, Fang, Jiang, Cheng-Ying, Lv, Da-Wei, Mao, Bei-Bei, Zhang, Qiang, Yuan, Zeng-Qiang, Wang, Yan |
---|---|
Format: | Online |
Language: | English |
Published: |
Sun Yat-sen University Cancer Center
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013303/ |
Similar Items
-
Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
by: Hautmann, Anke H., et al.
Published: (2014) -
Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia
by: Bower, Regina S., et al.
Published: (2012) -
Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant
by: Shiba, Eisuke, et al.
Published: (2016) -
Oncogenic Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Oral Cavity: A Case Report
by: Yang, In Myung, et al.
Published: (1997) -
Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors
by: Andreopoulou, Panagiota, et al.
Published: (2011)